dihydroxyphenylalanine has been researched along with 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kell, A; Lin, HY; Patel, D; Simard, B; Tian, G; Xiang, B | 1 |
| Ambrosini, V; Balogova, S; Beheshti, M; Bozkurt, MF; Chiti, A; Decristoforo, C; Delgado-Bolton, R; Fanti, S; Giammarile, F; Kjaer, A; Kunikowska, J; Oyen, WJG; Rubello, D; Sundin, A; Virgolini, I | 1 |
2 other study(ies) available for dihydroxyphenylalanine and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
| Article | Year |
|---|---|
The cell labeling efficacy, cytotoxicity and relaxivity of copper-activated MRI/PET imaging contrast agents.
Topics: Animals; Cell Line; Chelating Agents; Contrast Media; Copper; Dihydroxyphenylalanine; Dopamine Agents; Ferrosoferric Oxide; Heterocyclic Compounds, 1-Ring; Magnetic Resonance Imaging; Magnetics; Manganese Compounds; Materials Testing; Molecular Structure; Nanoparticles; Oxides; Positron-Emission Tomography; Rats; Rats, Inbred Lew; Stem Cells | 2011 |
Guideline for PET/CT imaging of neuroendocrine neoplasms with
Topics: Dihydroxyphenylalanine; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Image Interpretation, Computer-Assisted; Neuroendocrine Tumors; Peptides; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Quality Control; Receptors, Somatostatin; Tissue Distribution | 2017 |